UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	February 23, 2018 4:00 P.M.

Form:	F-3
CIK: 0001541157 Company Name: Akari Therapeutics Plc File Number: 333-220052